sustainability

Sustainability Overview

Our vision, “to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally", encapsulates the Group’s inherent approach of conducting business ethically, ​​​​​​​with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.

OUR APPROACH TO SUSTAINABILITY

We recognise that doing business in a sustainable manner is integral to ensuring our future viability.  As such sustainability considerations underpin our strategy and  are integrated into our day-to-day-activities.

​​​​​​​Our material sustainability issues are grouped into 10 sustainability objectives which are aligned to the Group’s strategic objectives, the related capitals and the relevant key performance indicators ("KPIs"). The Audit & Risk Committee reviews and approves the sustainability objectives and the related KPIs. The Board monitors the sustainability performance with reference to these KPIs on a regular basis.

Material sustainability issues are determined through ongoing interactions with our key stakeholders with reference to:
• external factors impacting the Group’s business model and pursuit of strategic objectives;
• key business risks impacting the Group’s sustainability;
• the value exchange and/or opportunity cost of the applied intellectual, manufactured, human, social & relationship, natural and financial capitals to the business as well as the responsible management of these; and
• our responsibility to stakeholders and transparency in reporting with reference to the GRI  Sustainability Reporting Standards, King IV, Companies Act of South Africa, BBBEE Codes in South Africa, the JSE/FTSE Responsible Investment Index, the Carbon Disclosure Project  and the UN Global Compact.

ASSURANCE

Assurance in respect of the sustainability KPIs is obtained by means of a combined assurance approach, with ERM providing assurance on the key environmental, health and safety indicators in line with the AccountAbility AA1000 Assurance Standard, PwC providing assurance on the financial indicators and other assurance providers such as the Group’s Internal Audit and Empowerdex providing assurance on the balance of the indicators reported.

Contact Details

Jeanette Englund

+27 31 580 8600

JEnglund@aspenpharma.com

Downloads

2018 Supplementary Sustainability Documents

2018 Supplementary Sustainability Documents:

2018 Sustainability Data Supplement PDF 816KB
Environmental Management Principles PDF 145KB
Equity Report - Fine Chemicals Workforce Profile PDF 171KB
Equity Report - South African Operations Workforce Profile PDF 170KB
2018 Safety and Environmental Certifications

2018 Safety and environmental certifications:

Bad Oldesloe - ISO 50001 - English PDF 1.2MB
Bad Oldesloe - ISO 9001 and ISO 14001 PDF 412KB
Dandenong - ISO 14001 PDF 508KB
Dandenong - OHSAS 18001 PDF 510KB
Notre Dame de Bondeville - ISO 14001 PDF 578KB
Notre Dame de Bondeville - ISO 50001 PDF 532KB
Notre Dame de Bondeville - OHSAS 18001 PDF 534KB
OSS - ISO 14001 PDF 227KB
OSS - OHSAS 18001 PDF 534KB
South African Operations - ISO 14001 PDF 755KB
South African Operations - OHSAS 18001 PDF 810KB
Vallejo - OHSAS 18001 Certificate PDF 129KB
Vitória - ISO 14001 PDF 1.5MB
Vitória - OHSAS 18001  PDF 313KB

Intellectual
Capital

Read more

Manufactured
Capital

Read more

Human
Capital

Read more

Social & Relationship Capital

Read more

Natural
Capital

Read more

Financial
Capital

Read more

Intellectual Capital

 

Our intellectual capital supports our focused therapeutic basket of high quality, affordable medicines and products.

 

Strategic objective

To enhance access to high quality, affordable medicines

Aspen's sustainability objectives

Sustaining life and health through high quality, affordable medicines

Material KPIs

  • IMS Health (Pty) Limited value of total product pipeline for the next five years
  • Number of product recalls

Assurance provider: Internal Audit

 

Manufactured Capital

 

The investment in our API facilities and FDF manufacturing capabilities aimed at delivering integrated and operational synergies is a key enabler in supporting our mission to produce high quality, affordable medicines and products, enhancing access to healthcare in over 150 countries.

 

Strategic objective

To achieve strategic advantage through our integrated supply chain

Aspen's sustainability objectives

Sustaining a cost-competitive manufacturing base

Material KPIs

  • Return on total assets
  • Normalised EBITDA margin

Assurance provider: PwC

 

Human Capital

 

Built on the foundation of our values and a commitment to the Group Code of Conduct, we strive to provide a safe, challenging and rewarding environment for each of our employees.

 

Strategic objective

To provide a safe, challenging and rewarding environment for our employees

Aspen's sustainability objectives

Creating an environment in which our employees can thrive

Providing a safe working environment

Material KPIs

  • Average staff turnover
  • Average training spend per employee

Assurance provider: Internal Audit

  • Disabling incident frequency rate
  • Lost work day frequency rate

Assurance provider: ERM

 
 
 

Social & relationship Capital

 

Responsible corporate citizenship is more than a compliance requirement, it is fundamental to our objectives and the way we do business. We recognise that there are inseparable linkages between our sustainable growth, our relationships with our stakeholders and its contribution to society in the broader context.

 

Strategic objective

To practise good corporate citizenship

Aspen's sustainability objectives

Promoting equality

Conducting our business in a responsible manner

Preserving the environment

Managing the efficient utilisation of scarce resources

Material KPIs

  • BBBEE accreditation in South Africa*
  • Percentage of female employees
  • Percentage of females in top 100 positions in the Group
  • Percentage of black employees in South Africa*
  • Percentage of black employees in top 50 positions in South Africa

Assurance provider: Internal Audit

  • BBBEE accreditation in South Africa

Assurance provider: Empowerdex

  • Number of material incidents of legislative infringements
  • FTSE/JSE Responsible Investment Index score
* South African businesses only

Natural Capital

 

As a manufacturer of quality medicines, APIs and nutritional products, we are reliant on the conversion and use of natural capital in creating value for its stakeholders. We recognize that our operations directly and indirectly impact the environment and the Aspen Environmental Management Protocol affirms our commitment reducing our impact on the environment, responsible environmental management, conservation and protection across all of our operations.

 

Strategic objective

To practise good corporate citizenship

Aspen's sustainability objectives

Preserving the environment

Managing the efficient utilisation of scarce resources

Material KPIs

  • Carbon emissions
  • Waste recycled

Assurance provider: ERM

  • Water used
  • Electricity used
 
 
 
 
 

Financial Capital

 

We aim to create value for all of our stakeholders, by managing our financial capital in a commercially astute and diligent manner thereby harnessing opportunities for long-term sustainable economic growth.

 

Strategic objective

To create sustainable economic value for all of our stakeholders

Aspen's sustainability objectives

Adding economic value to stakeholders

Maintenance of financial health

Material KPIs

  • Growth in revenue
  • Growth in normalised headline earnings per share
  • Growth in normalised EBITDA
  • Return on ordinary shareholders’ equity
  • Operating cash flow per share
  • Leveraging ratio

Assurance provider: PwC